Patents by Inventor Colette Cozean

Colette Cozean has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230240984
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: October 28, 2022
    Publication date: August 3, 2023
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Publication number: 20230095199
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethyl sulfoxide (DMSO) to treat behavioral disorders, communication delays, and developmental delays. Several formulations disclosed herein are useful for treating broad autism phenotype disorders, including autism spectrum disorders (e.g., autism).
    Type: Application
    Filed: July 8, 2022
    Publication date: March 30, 2023
    Inventors: Stanley Jacob, Jesse Cozean, Colette Cozean
  • Publication number: 20220125699
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Application
    Filed: September 2, 2021
    Publication date: April 28, 2022
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Patent number: 11110048
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: September 7, 2021
    Assignee: INNOVATIVE BIODEFENSE, INC.
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Publication number: 20200297625
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: January 27, 2020
    Publication date: September 24, 2020
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Publication number: 20200179306
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethyl sulfoxide (DMSO) to treat behavioral disorders, communication delays, and developmental delays. Several formulations disclosed herein are useful for treating broad autism phenotype disorders, including autism spectrum disorders (e.g., autism).
    Type: Application
    Filed: October 10, 2019
    Publication date: June 11, 2020
    Inventors: Stanley Jacob, Jesse Cozean, Colette Cozean
  • Publication number: 20200138687
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Application
    Filed: January 6, 2020
    Publication date: May 7, 2020
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Patent number: 10596109
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: March 24, 2020
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Patent number: 10524997
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: January 7, 2020
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Publication number: 20190060201
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Application
    Filed: June 18, 2018
    Publication date: February 28, 2019
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Publication number: 20180214373
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Application
    Filed: December 1, 2017
    Publication date: August 2, 2018
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Patent number: 10010496
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: July 3, 2018
    Assignee: Innovative BioDefense, Inc.
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Publication number: 20180092838
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 5, 2018
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Patent number: 9855212
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 2, 2018
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Patent number: 9839609
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: December 12, 2017
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Publication number: 20170326057
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Application
    Filed: July 31, 2017
    Publication date: November 16, 2017
    Applicant: Innovative BioDefense, Inc.
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Patent number: 9717669
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: August 1, 2017
    Assignee: Innovative BioDefense, Inc.
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Patent number: 9186472
    Abstract: Several embodiments of the invention relate to devices for the removal of dimethyl sulfoxide (DMSO) or related compounds, or odors associated with DMSO or DMSO-related compounds. Several embodiments relate to methods of using the same. In several embodiments the devices include adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies.
    Type: Grant
    Filed: May 10, 2013
    Date of Patent: November 17, 2015
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Harvey L. Claussen
  • Patent number: 9186297
    Abstract: The invention relates generally to materials for facilitating the administration of dimethyl sulfoxide (DMSO) and related compounds. In one embodiment, the invention comprises a kit comprising items used for the safe and effective administration of DMSO. In another embodiment, the invention relates to indicating containers for holding or delivering DMSO.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: November 17, 2015
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Harvey L. Claussen, Colette Cozean, Jack De La Torre
  • Publication number: 20150290102
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Application
    Filed: July 19, 2013
    Publication date: October 15, 2015
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry